|
News Highlights
|
FDA Approval a Two-Edged Sword
for Neurotech Vendors
The statutory mission of the U.S. Food and Drug Administration
is to protect Americans from tainted foods and unsafe pharmaceuticals
and medical devices, but in recent months the FDA has been
accused of running interference for established makers of
neurotech devices who are confronted with competitive products.
In the most celebrated case, Plano, TX-based Advanced Neuromodulation
Systems Inc. (ANS) openly accused giant medical device manufacturer
Medtronic Inc. of manipulating the FDA to maintain a monopoly
in the implantable pulse generator (IPG) market. ANS argues
that Medtronic worked to torpedo an FDA ruling that would
have fast-tracked approval of an ANS competitor to the Medtronic
IPG. Click
here to subscribe.
|
|
|
Functional Electrical Stimulation
Converges in Cleveland
Neurotechnologists from all over the world met in Cleveland
in June at the annual meeting of the International Functional
Electrical Stimulation Society. Our report offers the highlights
of the meeting and reviews the state of the art in this pioneering
new field. Click
here for full article.
|
|
Venture
Capitalists Discuss Impediments to Funding
Several
Los Angeles area venture capitalists offered their ideas on
the status of funding for bioscience and medical device companies.
In particular, they spoke of the relationship between a strong
local venture capital community and biomedical industry.
Click here to
subscribe. |
|
|
NIH Releases Program for Neurotechnology
Research
The National Institutes
of Health in early October released a new program announcement
for Neurotechnology Research, Development, and Enhancement.
The new initiative encourages multidisciplinary research efforts
and involves several NIH institutes, including the National
Institute of Mental Health, the National Institute on Deafness
and Other Communication Disorders, National Institute of Child
Health and Human Development, National Institute of Neurological
Disorders and Stroke, National Institute on Drug Abuse, and
the National Institute on Aging. Click
here for full article.
|
|
Subscribe
Now!
Neurotech
Business Report is the premier publication serving the emeging market
for neurotechnology. Launced in 2001, this authoritative newsletter
brings you up-to-the-minute news and analysis of key developments
in the neurotechnology industry. Our award-winning team of editors
and analysts cover the companies, products, deals, financing activity,
and promise of neurotech.
Each monthly issue of Neurotech Business Report brings you in-depth
profiles of neurotech device manufacturers and research institutions.
You'll learn who the key players are in this emerging market and
the promising applications in health care, information processing,
training, and virtual reality. Plus, your subscription entitles
you to an e-mail alert service that brings you important news and
event bulletins as they happen. And you'll get on-line and print
editions of the newsletter at no additional cost, plus exclusive
access to our database of neurotech companies
and institutions.
What's in Neurotech Business
Report
|
Technologies
|
Application
Areas
|
Editorial
Features
|
-
Functional Electrical Stimulation
- Neural
Prostheses
- Neural
Networks
- Magnetic
Stimulation and Sensing
- Brain
Recording and Imaging
- Neural/Silicon
Hybrids
|
- Rehabilitation
- Sports
Training
- Computing
- Virtual
Reality
- Man/Machine
Interfaces
- Psychotherapy
- Pain Management
- Aerospace
|
- Company
Profiles
- Funding
Opportunities
- Venture
Capital Deals
- Regulatory
Issues
- Research
Institute Profiles
- Product
Directions
- Market
Strategies
- Conference
Reports
|
|
|
|
|
|
